Related Experiment Video
Updated: Jul 19, 2026
09:54
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
[Interactions between dopamine, serotonin and other internal reinforcement factors]
Izvestiia Akademii Nauk. Seriia Biologicheskaia
|October 7, 2006
Summary
This study analyzed literature on dopamine (DA), serotonin (5-HT), and regulatory peptides (RPs) from 1960-2005. It revealed complex interactions and established opponent-reciprocal dynamics between DA and 5-HT systems.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Extensive literature from 1960-2005 on neurotransmitters and peptides was reviewed.
- Understanding interactions between dopamine, serotonin, and regulatory peptides is crucial for neuroscience.
Purpose of the Study:
- To analyze and estimate interactions between dopamine (DA), serotonin (5-HT), reward factors, and regulatory peptides (RPs).
- To systemize complex cascade interactions within these neurochemical systems.
Main Methods:
- Creation of a comprehensive database detailing physiological effects, doses, administration routes, organism types, and receptor mechanisms.
- Systematic analysis of literature data from 1960-2005.
Main Results:
- A database was established, cataloging information on RP and biologically active compounds.
- Complex cascade interactions between DA, 5-HT, reward factors, and RPs were investigated and systemized.
- Opponent-reciprocal interactions between DA and 5-HT systems were identified and their integrative characteristics estimated.
Conclusions:
- The study provides a systematic overview of neurochemical interactions.
- Established opponent-reciprocal dynamics between dopamine and serotonin systems offer insights into reward pathways.
More Related Videos
08:49Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry
Published on: January 12, 2012
08:07Simultaneous Detection of c-Fos Activation from Mesolimbic and Mesocortical Dopamine Reward Sites Following Naive Sugar and Fat Ingestion in Rats
Published on: August 24, 2016
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:23Primary and Secondary Reinforcers
In psychology, reinforcement is a key concept in behavior modification. B.F. Skinner demonstrated this with his experiments involving rats in what is known as a Skinner box. The rats learned to press a lever to receive food, a primary reinforcer that fulfilled their innate need for nourishment.
Effective reinforcers for humans vary depending on the individual and the context. Primary reinforcers, such as food, water, sleep, shelter, and pleasure, have inherent value and satisfy basic biological...
Effective reinforcers for humans vary depending on the individual and the context. Primary reinforcers, such as food, water, sleep, shelter, and pleasure, have inherent value and satisfy basic biological...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:31Neurotransmitters
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.